Search results
Found 12413 matches for
Prof Paul Johnson and his Islet Transplant Research Group have been awarded Horizon 2020 Funding as part of the DRIVE Consortium to evaluate and develop novel biomaterials and macroencapsulation strategies for transplanting islets without immunosuppression. This new award adds to their current FP7 European Funding, in which the Group has been evaluating and optimising islet function and survival within the MAILPAN (Deymed) device, with 'first in man' implantation planned in Oxford for 2016.
Sign up to our newsletter
Sign up to our newsletter to receive the latest news, insights and events directly to your inbox.
Join our research community
Join the Restore-B research community for breast reconstruction